IFN-γ Antagonist includes a peptide-derived framework used to probe receptor interactions and competitive binding processes. Charged and polar residues modulate solubility and structural stability. Researchers employ it to examine steric requirements for recognition. Applications extend to ligand tuning, pathway mapping, and advanced peptide engineering.
CAT No: R2453
CAS No:158040-83-6
Synonyms/Alias:IFN-g Antagonist;158040-83-6;IFN-gamma Antagonist;IFN-|A Antagonist 1;MFCD30475311;HY-P4717;DA-64386;FI108757;CS-0656161;IFN-g Antagonist (H-L-Ala-L-Tyr-L-Cys(Acm)-L-Arg-L-Asp-Gly-L-Lys-L-Ile-Gly-L-Pro-L-Pro-L-Lys-L-Leu-L-Asp-L-Ile-L-Arg-L-Lys-L-Glu-L-Glu-L-Lys-L-Gln-L-Ile-OH);
IFN-g Antagonist is a specialized carbohydrate-based compound designed to modulate immune responses by selectively inhibiting the activity of interferon-gamma (IFN-γ), a key cytokine involved in immune regulation and inflammation. Engineered for research purposes, this antagonist offers a unique tool for scientists exploring the complex pathways of immune signaling. Its carbohydrate structure allows for specific interactions with IFN-γ or its receptor, providing a valuable means to dissect the underlying mechanisms of cytokine-mediated responses. The versatility and specificity of IFN-g Antagonist make it a preferred choice in studies seeking to unravel the intricacies of immune modulation and cytokine signaling networks.
Immunology Research: IFN-g Antagonist finds extensive application in immunology research, where it serves as a critical tool for investigating the role of IFN-γ in various immune processes. By blocking IFN-γ signaling, researchers can delineate the downstream effects on immune cell activation, differentiation, and cytokine production. This enables a deeper understanding of the cytokine's function in both innate and adaptive immunity, facilitating the development of novel therapeutic strategies and expanding knowledge of immune system regulation.
Inflammation Pathway Studies: In the context of inflammation research, this antagonist is employed to elucidate the contribution of IFN-γ to inflammatory cascades. Its ability to inhibit IFN-γ activity allows scientists to model inflammatory conditions with reduced cytokine signaling, providing insights into the molecular events driving tissue damage and immune cell infiltration. These studies are crucial for identifying potential targets for anti-inflammatory interventions and for mapping the complex interplay between cytokines in inflammatory diseases.
Autoimmune Disease Modeling: The use of IFN-g Antagonist in autoimmune disease modeling enables researchers to simulate conditions of impaired IFN-γ signaling. By incorporating this compound into in vitro or in vivo models, scientists can assess how diminished IFN-γ activity influences disease onset, progression, and immune tolerance. Such studies are instrumental in identifying the cytokine's specific roles in autoimmune pathogenesis and in evaluating the therapeutic potential of IFN-γ modulation in various disease states.
Cell Signaling Pathway Analysis: Signal transduction studies benefit significantly from the inclusion of IFN-g Antagonist, as it allows for the targeted disruption of IFN-γ-mediated pathways. Researchers can employ this compound to investigate the downstream molecular events triggered by IFN-γ binding, such as the activation of STAT1 and other signaling proteins. By selectively blocking these pathways, the antagonist offers a precise approach to mapping the cellular responses regulated by IFN-γ and to distinguishing its effects from those of other cytokines.
Translational Research and Drug Development: In translational research settings, the antagonist is utilized to validate potential drug targets and to screen candidate molecules that modulate IFN-γ activity. Its use in preclinical models helps to assess the efficacy and mechanism of action of novel compounds, supporting the identification of promising leads for further development. The ability to selectively inhibit IFN-γ signaling also aids in predicting potential off-target effects and refining therapeutic approaches aimed at immune modulation. IFN-g Antagonist thus serves as a foundational tool across a broad spectrum of scientific investigations, driving progress in immunology, inflammation, and translational research.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More